Market Research Reports, Inc. has announced the addition of “Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2017” research report to their offering. See more at - http://mrr.cm/UKi

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: June 27, 2017
 Number of Pages: 73
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 2,000
Price For Site User License: USD 4,000
Price For Global User License: USD 6,000
Delivery Time: Within 24 Hours (During Working
Days)

3. www.MarketResearchReports.com
About the Report
Influenza A Virus, H7N9 Subtype Infections -
Pipeline Review, H1 2017, provides an overview of
the Influenza A Virus, H7N9 Subtype Infections
(Infectious Disease) pipeline landscape.
Avian influenza A (H7N9) is a subtype of influenza
viruses. This infection is seen both in humans and
birds. Infection is caused when a person is
exposure to infected poultry or contaminated
environments.

4. www.MarketResearchReports.com
Key Highlights;
Influenza A Virus, H7N9 Subtype Infections - Pipeline
Review, H1 2017, provides comprehensive information
on the therapeutics under development for Influenza A
Virus, H7N9 Subtype Infections (Infectious Disease),
complete with analysis by stage of development, drug
target, mechanism of action (MoA), route of
administration (RoA) and molecule type.
The guide covers the descriptive pharmacological
action of the therapeutics, its complete research and
development history and latest news and press
releases.
The Influenza A Virus, H7N9 Subtype Infections
(Infectious Disease) pipeline guide also reviews of key
players involved in therapeutic development for
Influenza A Virus, H7N9 Subtype Infections and features
dormant and discontinued projects.

5. www.MarketResearchReports.com
Key Highlights; Continues…
The guide covers therapeutics under Development by
Companies /Universities /Institutes, the molecules
developed by Companies in Phase II, Phase I,
Preclinical and Discovery stages are 4, 6, 11 and 2
respectively.
Influenza A Virus, H7N9 Subtype Infections (Infectious
Disease) pipeline guide helps in identifying and tracking
emerging players in the market and their portfolios,
enhances decision making capabilities and helps to
create effective counter strategies to gain competitive
advantage.
The guide is built using data and information sourced
from Publisher’s proprietary databases,
company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and
featured press releases from company/university sites
and industry-specific third party sources.

6. www.MarketResearchReports.com
Scope:
The pipeline guide provides a snapshot of the global
therapeutic landscape of Influenza A Virus, H7N9
Subtype Infections (Infectious Disease).
The pipeline guide reviews pipeline therapeutics for
Influenza A Virus, H7N9 Subtype Infections (Infectious
Disease) by companies and universities/research
institutes based on information derived from company
and industry-specific sources.
The pipeline guide covers pipeline products based on
several stages of development ranging from pre-
registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles
for the pipeline products which comprise, product
description, descriptive licensing and collaboration
details, R&D brief, MoA & other developmental
activities.

7. www.MarketResearchReports.com
Scope: Continues…
The pipeline guide reviews key companies involved in
Influenza A Virus, H7N9 Subtype Infections (Infectious
Disease) therapeutics and enlists all their major and
minor projects.
The pipeline guide evaluates Influenza A Virus, H7N9
Subtype Infections (Infectious Disease) therapeutics
based on mechanism of action (MoA), drug target, route
of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and
discontinued pipeline projects.
The pipeline guide reviews latest news related to
pipeline therapeutics for Influenza A Virus, H7N9
Subtype Infections (Infectious Disease)
Additionally, various dynamic tracking processes
ensure that the most recent developments are captured
on a real time basis.

8. www.MarketResearchReports.com
Reasons to buy:
Procure strategically important competitor information,
analysis, and insights to formulate effective R&D
strategies.
Recognize emerging players with potentially strong
product portfolio and create effective counter-strategies
to gain competitive advantage.
Find and recognize significant and varied types of
therapeutics under development for Influenza A Virus,
H7N9 Subtype Infections (Infectious Disease).
Classify potential new clients or partners in the target
demographic.
Develop tactical initiatives by understanding the focus
areas of leading companies.
Plan mergers and acquisitions meritoriously by
identifying key players and it’s most promising pipeline
therapeutics.

9. www.MarketResearchReports.com
Reasons to buy: Continues…
Formulate corrective measures for pipeline projects by
understanding Influenza A Virus, H7N9 Subtype
Infections (Infectious Disease) pipeline depth and focus
of Indication therapeutics.
Develop and design in-licensing and out-licensing
strategies by identifying prospective partners with the
most attractive projects to enhance and expand
business potential and scope.
Adjust the therapeutic portfolio by recognizing
discontinued projects and understand from the know-
how what drove them from pipeline.

10. www.MarketResearchReports.com
Report Coverage:
1. Introduction
2. Report Coverage
3. Influenza A Virus, H7N9 Subtype Infections -
Overview
4. Influenza A Virus, H7N9 Subtype Infections -
Therapeutics Development
5. Influenza A Virus, H7N9 Subtype Infections -
Therapeutics Assessment
6. Product Description
7. Influenza A Virus, H7N9 Subtype Infections - Drug
Profiles
8. Influenza A Virus, H7N9 Subtype Infections -
Dormant Projects
9. Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

11. www.MarketResearchReports.com
Company Coverage: (Partial List)
1. Beijing Minhai Biotechnology Co Ltd
2. Cocrystal Pharma Inc
3. EpiVax Inc
4. Fab'entech SA
5. Genentech Inc
6. GlaxoSmithKline Plc
7. iBio Inc
8. Inovio Pharmaceuticals Inc
9. Medicago Inc
10. Medigen Vaccine Biologics Corp
11. Nanotherapeutics Inc
12. NanoViricides Inc
13. NewLink Genetics Corp
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

12. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter
at:
http://www.marketresearchreports.com/subscribe-to-
newsletter

13. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/UKi
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Mr. Sudeep Chakravarty
Email : info@marketresearchreports.com
Phone: +1-302-703-9904 (USA) +91-8762746600 (India)